Follows people with portal hypertension after a TIPS liver shunt
Follows adults with high liver pressure after a TIPS shunt procedure.
Plain-language title generated from the registry record
Registry title: Freiburg TIPS Registry
Key facts
- Where
- Freiburg im Breisgau, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with clinically significant portal hypertension, with or without cirrhosis, who are scheduled to get a TIPS (a shunt placed in the liver veins) at the University Medical Center Freiburg.
- Age
- 18 to 100 years
- Sex
- All sexes can join.
- Disease stage
- Clinically significant portal hypertension, with or without cirrhosis of the liver.
Main reasons for not taking part
- People who withdraw their written informed consent cannot take part.
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT05782556, who can take part
Where in Germany
- University Medical Center Freiburg, Department of Medicine IIFreiburg im Breisgau, GermanyContact: Dominik Bettinger, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital Freiburg
- Trial code
- NCT05782556
- Record updated
- 1 May 2026
- Original description
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial.Read full original descriptionShow less
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for the Treatment of Portal Hypertension: an Observational Study
Patients with clinically significant portal hypertension allocated to implantation of a transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Medicine II of the University Medical Center Freiburg, Germany will be offered to participate in this prospective observational trial.
Clinical and laboratory as well as outcome parameters will be assessed before and within the first 12 months after TIPS implantation following a regular follow-up schedule with clinical visits at the University Medical Center Freiburg. During follow-up visits, serum/plasma samples and peripheral blood mononuclear cells (PBMC) are collected and stored in a associated biobank.
Inclusion: Patients allocated to TIPS implantation due to clinically significant cirrhotic and non-cirrhotic portal hypertension.
Exclusion: Withdrawal of written informed consent.